Total Payments
$2,473
2023 Payments
$265.25
Companies
22
Transactions
95
Medicare Patients
139
Medicare Billing
$16,347
Payment Breakdown by Category
Food & Beverage$1,845 (74.6%)
Travel$628.20 (25.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,845 | 92 | 74.6% |
| Travel and Lodging | $628.20 | 3 | 25.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $905.65 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $897.06 | 48 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $97.96 | 5 | $0 (2023) |
| Seattle Genetics, Inc. | $89.54 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $57.04 | 3 | $0 (2023) |
| Celgene Corporation | $50.83 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $41.78 | 2 | $0 (2023) |
| Incyte Corporation | $41.02 | 2 | $0 (2023) |
| EISAI INC. | $34.19 | 2 | $0 (2022) |
| ABBVIE INC. | $34.11 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $265.25 | 13 | Merck Sharp & Dohme LLC ($76.34) |
| 2022 | $88.47 | 5 | E.R. Squibb & Sons, L.L.C. ($33.72) |
| 2021 | $295.06 | 18 | AstraZeneca Pharmaceuticals LP ($55.96) |
| 2020 | $46.26 | 2 | Janssen Pharmaceuticals, Inc ($46.26) |
| 2019 | $985.31 | 17 | Merck Sharp & Dohme Corporation ($787.12) |
| 2018 | $326.26 | 23 | Janssen Pharmaceuticals, Inc ($303.06) |
| 2017 | $466.79 | 17 | Janssen Pharmaceuticals, Inc ($364.95) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/08/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: Hematology | ||||||
| 05/31/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 05/30/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Oncology | ||||||
| 05/10/2023 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Hematology | ||||||
| 05/09/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: ONCOLOGY | ||||||
| 04/14/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Oncology | ||||||
| 04/04/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 03/09/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.33 | General |
| 03/06/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: Hematology | ||||||
| 02/28/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Hematology | ||||||
| 08/01/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| 05/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Oncology | ||||||
| 03/18/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| Category: Oncology | ||||||
| 02/16/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Oncology | ||||||
| 11/17/2021 | GENZYME CORPORATION | SARCLISA (Biological), ELITEK | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 10/27/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Oncology | ||||||
| 10/20/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Oncology | ||||||
| 09/09/2021 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Oncology | ||||||
| 09/01/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/25/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2021 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR, TABRECTA | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 80 | 93 | $22,187 | $11,730 |
| 2022 | 2 | 59 | 66 | $17,090 | $4,617 |
Total Patients
139
Total Services
159
Medicare Billing
$16,347
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 43 | $10,621 | $5,907 | 55.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 36 | $6,624 | $3,452 | 52.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $4,942 | $2,371 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 29 | $9,135 | $2,475 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 37 | $7,955 | $2,142 | 26.9% |
About Dr. Juan Posada, M.D
Dr. Juan Posada, M.D is a Hematology & Oncology healthcare provider based in Temple, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508827361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Posada, M.D has received a total of $2,473 in payments from pharmaceutical and medical device companies, with $265.25 received in 2023. These payments were reported across 95 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,845).
As a Medicare-enrolled provider, Posada has provided services to 139 Medicare beneficiaries, totaling 159 services with total Medicare billing of $16,347. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Temple, TX
- Active Since 03/31/2006
- Last Updated 07/16/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1508827361
Products in Payments
- XARELTO (Drug) $874.76
- LENVIMA (Drug) $787.12
- KEYTRUDA (Biological) $102.64
- ADCETRIS (Biological) $89.54
- ENHERTU (Biological) $42.00
- MONJUVI (Drug) $41.02
- REBLOZYL (Biological) $37.25
- MEKINIST (Drug) $34.71
- Lenvima (Drug) $34.19
- VRAYLAR (Drug) $34.11
- LYNPARZA (Drug) $33.68
- XTANDI (Drug) $23.29
- ZONTIVITY (Drug) $23.20
- INVOKANA (Drug) $22.30
- CALQUENCE (Drug) $22.28
- Padcev (Drug) $18.49
- IBRANCE (Drug) $17.31
- OPDIVO (Biological) $17.26
- LUMAKRAS (Drug) $16.98
- Doptelet (Drug) $16.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Temple
Dr. Lucas Wong, M.d, M.D
Hematology & Oncology — Payments: $13,938
Hematology & Oncology $13,938
Dr. Rex Garland, D.o, D.O
Hematology & Oncology — Payments: $2,462
Hematology & Oncology $2,462
Dr. Sripriya Santhanam, M.d, M.D
Hematology & Oncology — Payments: $1,164
Hematology & Oncology $1,164
Khine Oo, M.d, M.D
Hematology & Oncology — Payments: $12.56
Hematology & Oncology $12.56
Dr. Daniel Hadlock, M.d, M.D
Hematology & Oncology
Hematology & Oncology
Dr. Eliseo Hervas, M.d, M.D
Hematology & Oncology
Hematology & Oncology